Clinical Trial

Imaging Study of Metastatic Prostate Cancer

Study Description

Hyperpolarized Carbon-13 Imaging of Metastatic Prostate Cancer

A pilot study with a group of up to 10 men with CRPC about to embark on a 6-month course of treatment with radium 223. Study participants will undergo anatomical MR imaging combined with the new hyperpolarized MRI (1 hour exam) prior to treatment.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Hyperpolarized Pyruvate (13C)

MRI contrast agent

Additional Information

Official Study Title

Hyperpolarized Carbon-13 Imaging of Metastatic Prostate Cancer

Clinical Trial ID

NCT02844647

ParticipAid ID

lejBye